Treatment of Nosocomial COVID-19

NCT04748588 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

46

Enrollment

OTHER

Sponsor class

Stopped Equipoise requirement no longer met.

Conditions

Covid19
Nosocomial Infection
SARS-CoV2 Infection

Interventions

DRUG: Anti-SARS-CoV-2 mAb

Sponsor

University of Calgary

Collaborators

[object Object]